Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Neurocrine Bioscienc (NASDAQ: NBIX)

$53.40 USD -$0.19 (-0.35%)
Last Price $53.4
Net Change $-0.19 (-0.35%)
Bid $48.5
Ask Price $54.87
Open Price $53.54
Previous Close Price $53.59
High Price $53.85
Low Price $52.56
Number of Trades 4,908
Volume 980,593
Fifty Two Week High $55.15 (2016-09-20)
Fifty Two Week Low $37.35 (2016-12-29)
Average Daily Volume 1,337,260
Share Outstanding 87,520 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $-0.51 (2017-02-14)
2nd Quarter Earnings $-0.43 (2016-11-02)
3nd Quarter Earnings $-0.46 (2016-08-03)
4th Quarter Earnings $-0.22 (2016-05-05)
PE Ratio $0
EPS Growth $-34.23
Recent Earnings $-0.51
Annual EPS $-1.4
Last Quarter EPS $
Market Capitalization $4.67B
Insider Shareholders % 0.048%
Annual Revenue $0B
No. Shares Outstanding 87,520
Inst. Shareholder % 96.87%
Annual Net Income $0B
TTM Net Profit Margin $101.22
1-Year Return 14.26%
3-Year Return 287.21%
5-Year Return 621.27%
5-Year Revenue Growth -80.62%
5-Year Earnings Growth -343.28%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -34.23%
Dividends per Share $
Stock Split Ratio
Beta 0.7
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.